In terms of the relationships of AMPK and IDH mutation, previous reports demonstrated the metabolic vulnerability of mutant IDH gliomas or glioblastomas to biguanides, such as metformin and phenformin, which activate AMPK by inhibiting mitochondrial respiratory chain complex 147–49. The gene discussed is IDH1; the disease is glioma.